Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS: CHGCY · Delayed Price · USD
18.56
+0.57 (3.17%)
Jul 3, 2024, 12:26 PM EDT - Market closed
Chugai Pharmaceutical Co. Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2003 |
---|---|---|---|---|---|---|
Cash & Equivalents | 458,674 | 222,169 | 267,753 | 212,333 | 203,941 | Upgrade
|
Short-Term Investments | 280,308 | 280,938 | 204,217 | 166,287 | 129,117 | Upgrade
|
Cash & Cash Equivalents | 738,982 | 503,107 | 471,970 | 378,620 | 333,058 | Upgrade
|
Cash Growth | 46.88% | 6.60% | 24.66% | 13.68% | 33.55% | Upgrade
|
Receivables | 320,348 | 514,283 | 356,009 | 253,354 | 181,641 | Upgrade
|
Inventory | 273,480 | 292,206 | 208,838 | 183,893 | 168,122 | Upgrade
|
Other Current Assets | 33,616 | 26,941 | 26,844 | 19,039 | 16,859 | Upgrade
|
Total Current Assets | 1,366,426 | 1,336,537 | 1,063,661 | 834,906 | 699,680 | Upgrade
|
Property, Plant & Equipment | 420,701 | 386,651 | 352,107 | 297,490 | 265,308 | Upgrade
|
Long-Term Investments | 1,254 | -279,101 | -201,824 | -163,446 | -126,159 | Upgrade
|
Intangible Assets | 19,860 | 25,141 | 21,974 | 23,880 | 23,540 | Upgrade
|
Other Long-Term Assets | 124,306 | 400,530 | 302,776 | 242,668 | 196,546 | Upgrade
|
Total Long-Term Assets | 566,121 | 533,221 | 475,033 | 400,592 | 359,235 | Upgrade
|
Total Assets | 1,932,547 | 1,869,758 | 1,538,694 | 1,235,498 | 1,058,915 | Upgrade
|
Accounts Payable | 54,234 | 209,835 | 152,266 | 100,396 | 77,635 | Upgrade
|
Deferred Revenue | 31 | 79 | 86 | 80 | 252 | Upgrade
|
Current Debt | 6,975 | 6,434 | 6,550 | 6,649 | 7,263 | Upgrade
|
Other Current Liabilities | 226,977 | 207,382 | 168,520 | 128,945 | 94,118 | Upgrade
|
Total Current Liabilities | 288,217 | 423,730 | 327,422 | 236,070 | 179,268 | Upgrade
|
Long-Term Debt | 6,480 | -430 | -490 | -564 | -643 | Upgrade
|
Other Long-Term Liabilities | 12,269 | 22,071 | 23,745 | 19,989 | 26,305 | Upgrade
|
Total Long-Term Liabilities | 18,749 | 21,641 | 23,255 | 19,425 | 25,662 | Upgrade
|
Total Liabilities | 306,966 | 445,371 | 350,677 | 255,495 | 204,930 | Upgrade
|
Total Debt | 13,455 | 14,109 | 16,040 | 11,284 | 12,752 | Upgrade
|
Debt Growth | -4.64% | -12.04% | 42.15% | -11.51% | 5831.16% | Upgrade
|
Common Stock | 73,202 | 73,202 | 73,202 | 73,202 | 73,016 | Upgrade
|
Retained Earnings | 1,488,738 | 1,293,352 | 1,054,050 | 849,093 | 722,076 | Upgrade
|
Comprehensive Income | -5,714 | -10,972 | -7,457 | -9,878 | -8,143 | Upgrade
|
Shareholders' Equity | 1,625,580 | 1,424,387 | 1,188,017 | 980,003 | 853,985 | Upgrade
|
Total Liabilities and Equity | 1,932,546 | 1,869,758 | 1,538,694 | 1,235,498 | 1,058,915 | Upgrade
|
Net Cash / Debt | 725,527 | 488,998 | 455,930 | 367,336 | 320,306 | Upgrade
|
Net Cash / Debt Growth | 48.37% | 7.25% | 24.12% | 14.68% | 28.55% | Upgrade
|
Net Cash Per Share | 440.92 | 297.20 | 277.12 | 223.29 | 194.77 | Upgrade
|
Working Capital | 1,078,209 | 912,807 | 736,239 | 598,836 | 520,412 | Upgrade
|
Book Value Per Share | 988.07 | 866.00 | 722.57 | 596.31 | 520.04 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.